An HLA-B27 polymorphism (B*2710) that is critical for T-cell recognition has limited effects on peptide specificity

Tissue Antigens

Volumn 51, Issue 1, 1998, Pages 1-9

  Garcia F ^a   Rognan, D ^b   Lamas, J R ^a   Marina, A ^a   Lopez De Castro J A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b ETH ZURICH   (Switzerland)

Author keywords

B*2710; HLA B27; Molecular modeling; Peptide motif

Indexed keywords

GLUTAMINE; HLA B27 ANTIGEN; VALINE;

AMINO ACID SEQUENCE; ANTIGEN SPECIFICITY; ANTIGENICITY; ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CROSS REACTION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MOLECULAR MODEL; PRIORITY JOURNAL; SEQUENCE ANALYSIS; T LYMPHOCYTE;

EID: 0031973454     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb02941.x     Document Type: Article

References (40)

1. Fernandez-Viña MA, Lázaro AM, Nulf CJ, Stastny P. Nucleotide sequence of novel subtypes of HLA-B27, B55, and B57 (abstract). Hum Immunol 1996: 49: 43.
2. Vega MA, Wallace L, Rojo S, Bragado R, Aparicio P, Lopez de Castro JA. Delineation of functional sites in HLA-B27 antigens. Molecular analysis of HLA-B27 variant Wewak I defined by cytolytic T lymphocytes. J Immunol 1985: 135: 3323-32.
3. Vega MA, Bragado R, Ivanyi P, Pelaez JL, Lopez de Castro JA. Molecular analysis of a functional subtype of HLA-B27. A possible evolutionary pathway for HLA-B27 polymorphism. J Immunol 1986: 137: 3557-65.
4. Rudwaleit M, Bowness P, Wordsworth P. The nucleotide sequence of HLA-B*2704 reveals a new amino acid substitution in exon 4 which is also present in HLA-B*2706. Immunogenetics 1996: 43: 160-2.
5. Lopez D, Garcia Hoyo R, Lopez de Castro JA. Clonal analysis of alloreactive T cell responses against the closely related B*2705 and B*2703 subtypes. Implications for HLA-B27 association to spondyloarthropathy. J Immunol 1994: 152: 5557-71.
6. Calvo V, Rojo S, Lopez D, Galocha B, Lopez de Castro JA. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism. J Immunol 1990: 144: 4038-45.
7. Lopez D, Rojo S, Calvo V, Lopez de Castro JA. Peptide-presenting similarities among functionally distant HLA-B27 subtypes revealed by alloreactive T lymphocytes of unusual specificity. J Immunol 1992: 148: 996-1002.
8. Villadangos JA, Galocha B, Garcia Hoyo R, Lopez D, Garcia F, Lopez de Castro JA. Structure of HLA-B27-specific T cell epitopes. Antigen presentation in B*2703 is limited mostly to a subset of the antigenic determinants on B*2705. Eur J Immunol 1994: 24: 2548-55.
9. Cowan EP, Jelachich ML, Coligan JE, Biddison WE. Site-directed mutagenesis of an HLA-A3 gene identifies amino acid 152 as crucial for major-histocompatibility-complex-restricted and alloreactive cytotoxic-T-lymphocyte recognition. Proc Natl Acad Sci U S A 1987: 84: 5014-8.
10. Jelachich ML, Cowan EP, Turner RV, Coligan JE, Biddison WE. Analysis of the molecular basis of HLA-A3 recognition by cytotoxic T cells using defined mutants of the HLA-A3 molecule. J Immunol 1988: 141: 1108-13.
11. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF, Ziegler A. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens. New tools for genetic analysis. Cell 1978: 14: 9-20.
12. Ellis SA, Taylor C, McMichael A. Recognition of HLA-B27 and related antigens by a monoclonal antibody. Hum Immunol 1982: 5: 49-59.
13. Garcia F, Marina A, Lopez de Castro JA. Lack of carboxyl-terminal tyrosine distinguishes the B*2706-bound peptide repertoire from those of B*2704 and other HLA-B27 subtypes associated to ankylosing spondylitis. Tissue Antigens 1997: 49: 215-21.
14. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991: 351: 290-6.
15. Galocha B, Lamas JR, Villadangos JA, Albar JP, Lopez de Castro JA. Binding of peptides naturally presented by HLA-B27 to the differentially disease-associated B*2704 and B*2706 subtypes, and to mutants mimicking their polymorphism. Tissue Antigens 1996: 48: 509-518.
16. Pearlman DA, Case DA, Caldwell JC et al. AMBER 4.1, University of California, 1995.
17. Cornell WD, Cieplak P, Bayly CI et al. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J Am Chem Soc 1995: 117: 5179-97.
18. Madden DR, Gorga JC, Strominger JL, Wiley DC. The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992: 70: 1035-48.
19. Rognan D, Scapozza L, Folkers G, Daser A. Rational design of nonnatural peptides as high-affinity ligands for the HLA-B*2705 human leukocyte antigen. Proc Natl Acad Sci U S A 1995: 92: 753-7.
20. Rognan D, Krebs S, Kuonen O, Lamas JR, Lopez de Castro JA, Folkers G. Fine specificity of antigen binding to two class I major histocompatibility proteins (B*2705 and B*2703) differing in a single amino acid residue. J Comput Aid Mol Des (in press).
21. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys 1983: 70: 926-35.
22. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 1996: 384: 134-41.
23. Garcia KC, Degano M, Stanfield RL et al. An αβ T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 1996: 274: 209-19.
24. Rojo S, Garcia F, Villadangos JA, Lopez de Castro JA. Changes in the repertoire of peptides bound to HLA-B27 subtypes and to site-specific mutants inside and outside pocket B. J Exp Med 1993: 177: 613-20.
25. Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC. Identification of self peptides bound to purified HLA-B27. Nature 1991: 353: 326-9.
26. Rotzschke O, Falk K, Stevanovic S, Gnau V, Jung G, Rammensee HG. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics 1994: 39: 74-7.
27. Villadangos JA, Galocha B, Garcia F, Albar JP, Lopez de Castro JA. Modulation of peptide binding by HLA-B27 polymorphism in pockets A and B, and peptide specificity of B*2703. Eur J Immunol 1995: 25: 2370-7.
28. Rognan D, Zimmermann N, Jung G, Folkers G. Molecular dynamics study of a complex between the human histocompatibility antigen HLA-A2 and the IMP58-66 nonapeptide from influenza virus matrix protein. Eur J Biochem 1992: 208: 101-13.
29. Rognan D, Scapozza L, Folkers G, Daser A. Molecular dynamics simulation of MHC-peptide complexes as a tool for predicting potential T cell epitopes. Biochemistry 1994: 33: 11476-85.
30. Boisgérault F, Tieng V, Stolzenberg MC et al. Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants: implications for susceptibility to spondylarthropathies. J Clin Invest 1996: 98: 2764-70.
31. Van Endert PM, Riganelli D, Greco G et al. The peptide-binding motif for the human transporter associated with antigen processing. J Exp Med 1995: 182: 1883-95.
32. b Science 1992: 257: 919-27.
33. b-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc Natl Acad Sci U S A 1995: 92: 2479-83.
34. Parham P, Adams EJ, Arnett KL. The origins of HLA-A,B,C polymorphism. Immunol Rev 1995: 143: 141-80.
35. Koradi R, Billeter M, Wüthrich K. MOLMOL: A program for display and analysis of macromolecular structures. J Mol Graph 1996: 14: 51-5.
36. Collaborative computational project, Number 4: The CCP4 suite, programs for protein crystallography. Acta Cryst 1994: 50: 760-3.
37. Rammensee HG, Friede T, Stevanoviic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995: 41: 178-228.
38. Fiorillo MT, Meadows L, D'Amato M et al. Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes. Eur J Immunol 1997: 27: 368-73.
39. Garcia F, Galocha B, Villadangos JA et al. HLA-B27 (B*2701) specificity for peptides lacking Arg2 is determined by polymorphism outside the B pocket. Tissue Antigens 1997: 49: 580-7.
40. Garcia F, Marina A, Albar JP, Lopez de Castro JA. HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. Tissue Antigens 1997: 49: 23-8.